Role of extracellular and intracellular microRNAs in sepsis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 11, 2014, Pages 2155-2162

  Essandoh, Kobina ^a   Fan, Guo Chang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarkers; Inflammatory response; MiRNAs; NF B; Sepsis

Indexed keywords

I KAPPA B ALPHA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MICRORNA; MICRORNA 125B; MICRORNA 126; MICRORNA 146A; MICRORNA 149; MICRORNA 15; MICRORNA 150; MICRORNA 16; MICRORNA 200; MICRORNA 203; MICRORNA 221; MICRORNA 223; MICRORNA 4772; MICRORNA 579; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

BIOGENESIS; BLOOD; BLOOD SAMPLING; BREAST MILK; DISEASE SEVERITY; HUMAN; INFLAMMATION; PROGNOSIS; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SWEAT; URINE;

EID: 84908388218     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.07.021     Document Type: Review

References (70)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29(7):1303-1310.
2. Levy M.M., Artigas A., Phillips G.S., Rhodes A., Beale R., Osborn T., Dellinger R.P. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect. Dis. 2012, 12(12):919-924.
3. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101(6):1481-1483.
4. Sankar V., Webster N.R. Clinical application of sepsis biomarkers. J. Anesth. 2013, 27(2):269-283.
5. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340(17):448-454.
6. Bloos F., Marshall J.C., Dellinger R.P., Vincent J.-L., Gutierrez G., Rivers E., Brunkhorst F.M. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit. Care 2011, 15(2):R88.
7. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410(6832):1103-1107.
8. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11(9):597-610.
9. Baek D., Villén J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455(7209):64-71.
10. Ardekani A.M., Naeini M.M. The Role of MicroRNAs in Human Diseases. Avicenna J. Med. Biotechnol. 2010, 2(4):161-179.
11. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141(5):672-675.
12. Tsujimoto H., Ono S., Efron P.a, Scumpia P.O., Moldawer L.L., Mochizuki H. Role of Toll-like receptors in the development of sepsis. Shock 2008, 29(3):315-321.
13. Kaisho T., Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta. 2002, 1589(1):1-13.
14. Lee Y., Jeon K., Lee J.-T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002, 21(17):4663-4670.
15. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425(6956):415-419.
16. Lund E., Güttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303(5654):95-98.
17. Fabian M.R., Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 2012, 19(6):586-593.
18. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9(2):102-114.
19. Yang X., Du W.W., Li H., Liu F., Khorshidi A., Rutnam Z.J., Yang B.B. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 2013, 41(21):9688-9704.
20. Lee I., Ajay S.S., Yook J.I., Kim H.S., Hong S.H., Kim N.H., Athey B.D. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res. 2009, 19(7):1175-1183.
21. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Zhang C.-Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18(10):997-1006.
22. Okamura K., Phillips M.D., Tyler D.M., Duan H., Chou Y., Lai E.C. The regulatory activity of microRNA* species has substantial influence on microRNA and 3' UTR evolution. Nat. Struct. Mol. Biol. 2008, 15(4):354-363.
23. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9(8):581-593.
24. Ramachandran S., Palanisamy V. Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdiscip. Rev. RNA 2012, 3(2):286-293.
25. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2009, 2(100):1-11.
26. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39(16):7223-7233.
27. Vickers K.C., Remaley A.T. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 2012, 23(2):91-97.
28. Vasilescu C., Rossi S., Shimizu M., Tudor S., Veronese A., Ferracin M., Calin G.A. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009, 4(10):e7405.
29. Vincent J.-L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units. Crit. Care Med. 1998, 26(11):1793-1800.
30. Roderburg C., Luedde M., Vargas Cardenas D., Vucur M., Scholten D., Frey N., Luedde T. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013, 8(1):e54612.
31. Wang J., Yu M., Yu G., Bian J., Deng X., Wan X., Zhu K. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 2010, 394(1):184-188.
32. Wang L., Wang H.-C., Chen C., Zeng J., Wang Q., Zheng L., Yu H.-D. Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients. Exp. Ther. Med. 2013, 5(4):1101-1104.
33. Wang H., Zhang P., Chen W., Feng D., Jia Y., Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 2012, 7(6):e38885.
34. Wang X., Huang W., Yang Y., Wang Y., Peng T., Chang J., Fan G.-C. Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis. Biochim. Biophys. Acta 2014, 1842(5):701-711.
35. Ma Y., Vilanova D., Atalar K., Delfour O., Edgeworth J., Ostermann M., Lord G.M. Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis. PLoS One 2013, 8(10):e75918.
36. Standage S.W., Wong H.R. Biomarkers for pediatric sepsis and septic shock. Expert Rev. Anti-Infect. Ther. 2011, 9(1):71-79.
37. Wang H., Meng K., Chen W.J., Feng D., Jia Y., Xie L. Serum miR-574-5p: a prognostic predictor of sepsis patients. Shock 2012, 37(3):263-267.
38. Sun X., Icli B., Wara A.K., Belkin N., He S., Kobzik L., Feinberg M.W. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J. Clin. Investig. 2012, 122(6):1973-1990.
39. Li Y., Dalli J., Chiang N., Baron R.M., Quintana C., Serhan C.N. Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity 2013, 39(5):885-898.
40. Tacke F., Roderburg C., Benz F., Cardenas D.V., Luedde M., Hippe H.J., Luedde T. Levels of Circulating miR-133a Are Elevated in Sepsis and Predict Mortality in Critically Ill Patients. Crit. Care Med. 2014, 42(5):1096-1104.
41. Wu S.C., Yang J.C.S., Rau C.S., Chen Y.C., Lu T.H., Lin M.W., Hsieh C.H. Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture. PLoS One 2013, 8(10):e77936.
42. Huang J., Sun Z., Yan W., Zhu Y., Lin Y., Chen J., Wang J. Identification of microRNA as sepsis biomarker based on miRNAs regulatory network analysis. BioMed Res. Int. 2014, 2014:594350.
43. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42(2):145-151.
44. Kawagoe T., Sato S., Matsushita K., Kato H., Matsui K., Kumagai Y., Akira S. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 2008, 9(6):684-691.
45. Ma X., Becker Buscaglia L.E., Barker J.R., Li Y. MicroRNAs in NF-kappaB signaling. J. Mol. Cell Biol. 2011, 3(3):159-166.
46. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11(5):373-384.
47. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348(2):138-150.
48. Chen X.M., Splinter P.L., O'Hara S.P., LaRusso N.F. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 2007, 282(39):28929-28938.
49. Wendlandt E.B., Graff J.W., Gioannini T.L., McCaffrey A.P., Wilson M.E. The role of MicroRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation. Innate Immunity. 2012, 18(6):846-855.
50. Xu G., Zhang Z., Xing Y., Wei J., Ge Z., Liu X., Huang X. MicroRNA-149 negatively regulates TLR-triggered inflammatory response in macrophages by targeting MyD88. J. Cell. Biochem. 2014, 115(5):919-927.
51. Wei J., Huang X., Zhang Z., Jia W., Zhao Z., Zhang Y., Xu G. MyD88 as a target of microRNA-203 in regulation of lipopolysaccharide or Bacille Calmette-Guerin induced inflammatory response of macrophage RAW264.7 cells. Mol. Immunol. 2013, 55(3-4):303-309.
52. Taganov K.D., Boldin M.P., Chang K., Baltimore D. NF-κB-dependent induction of micro-RNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. PNAS 2006, 103(33):12481-12486.
53. Curtale G., Mirolo M., Renzi T.A., Rossato M., Bazzoni F., Locati M. Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(28):11499-11504.
54. Li T., Morgan M.J., Choksi S., Zhang Y., Kim Y.S., Liu Z. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 2010, 11(9):799-805.
55. Chen R., Alvero A.B., Silasi D.A., Kelly M.G., Fest S., Visintin I., Mor G. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008, 27(34):4712-4723.
56. Feng X., Wang H., Ye S., Guan J., Tan W., Cheng S., Zhou Y. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One 2012, 7(12):e52782.
57. El Gazzar M., McCall C.E. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 2010, 285(27):20940-20951.
58. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., Croce C.M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 2007, 179(8):5082-5089.
59. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001, 20(6):669-676.
60. Sheedy F.J., Palsson-McDermott E., Hennessy E.J., Martin C., O'Leary J.J., Ruan Q., O'Neill L.A. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 2010, 11(2):141-147.
61. Zschiedrich I., Hardeland U., Krones-Herzig A., Berriel Diaz M., Vegiopoulos A., Müggenburg J., Herzig S. Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 2008, 112(2):264-276.
62. Ho P.C., Chang K.C., Chuang Y.S., Wei L.N. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J. 2011, 25(5):1758-1766.
63. Sweeney T.E., Suliman H.B., Hollingsworth J.W., Piantadosi C.A. Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS One 2010, 5(7):e11606.
64. Haden D.W., Suliman H.B., Carraway M.S., Welty-Wolf K.E., Ali A.S., Shitara H., Piantadosi C.A. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 2007, 176(8):768-777.
65. Fisher N.C., Wilde J.T., Roper J., Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?. Gut 2000, 46(4):534-539.
66. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Fisher C.J. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 2001, 344(10):699-709.
67. Moore C.C., McKillop I.H., Huynh T. MicroRNA expression following activated protein C treatment during septic shock. J. Surg. Res. 2013, 182(1):116-126.
68. Wang Z., Liang Y., Tang H., Chen Z., Li Z., Hu X., Ma Z. Dexamethasone down-regulates the expression of microRNA-155 in the livers of septic mice. PLoS One 2013, 8(11):e80547.
69. Iskander K.N., Osuchowski M.F., Stearns-Kurosawa D.J., Kurosawa S., Stepien D., Valentine C., Remick D.G. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol. Rev. 2013, 93(3):1247-1288.
70. Russell J.A., Walley K.R. Update in sepsis 2012. Am. J. Respir. Crit. Care Med. 2013, 187(12):1303-1307.